Cargando…

A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine

Detalles Bibliográficos
Autores principales:	Lospinoso, Kristen, Nichols, Cameron S., Malachowski, Stephen J., Mochel, Mark C., Nutan, Fnu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149168/ https://www.ncbi.nlm.nih.gov/pubmed/34056055 http://dx.doi.org/10.1016/j.jdcr.2021.05.010

Ejemplares similares

Reply to “Widespread Cutaneous Reaction to the Johnson & Johnson Ad26.Cov2.S Vaccine”
por: Malachowski, Stephen J., et al.
Publicado: (2022)

Cutaneous small vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination
por: Berry, Corbett T., et al.
Publicado: (2021)

Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine
por: Antonios, Bana, et al.
Publicado: (2022)

Response to Berry et al’s “Cutaneous small-vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination”
por: Matthews, Natalie H., et al.
Publicado: (2022)

Vaccine-induced massive pulmonary embolism and thrombocytopenia following a single dose of Janssen Ad26.COV2.S vaccination
por: Curcio, Rosa, et al.
Publicado: (2022)

Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS
por: John, Binu V., et al.
Publicado: (2022)

Widespread cutaneous reaction to the Johnson & Johnson Ad26.COV2.S vaccine
por: Sowell, Josiah, et al.
Publicado: (2021)

Ad26.CoV2 S: Severe cutaneous adverse reaction with acute generalised exanthematous pustulosis and DRESS syndrome: case report
Publicado: (2021)

A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)()
por: Castan, Maxime, et al.
Publicado: (2022)

Magnetic Janssen effect
por: Thorens, L., et al.
Publicado: (2021)

Nivolumab-Induced de novo Discoid Lupus Erythematosus
por: Manjunath, Jaya, et al.
Publicado: (2022)

Ted Janssen and aperiodic crystals
por: de Boissieu, Marc
Publicado: (2019)

TTS with Janssen's COVID-19 vaccine
Publicado: (2021)

Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population
por: Salmon, Daniel A., et al.
Publicado: (2022)

Allergic reactions to the Ad26.COV2.S vaccine in South Africa
por: Peter, Jonny, et al.
Publicado: (2021)

Reply to the letter from Janssen et al
por: Vlasveld, L.T., et al.
Publicado: (1994)

Anxiety disorders with Janssen's COVID-19 vaccine
Publicado: (2021)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

The astronomer Jules Janssen: a globetrotter of celestial physics
por: Launay, Françoise
Publicado: (2012)

Janssen COVID-19 vaccine-related tinnitus and dizziness
Publicado: (2021)

PRAC: blood clots with Janssen's COVID-19 vaccine
Publicado: (2021)

Syndrome VITT : le vaccin Janssen également concerné ?
por: Manus, Jean-Marie
Publicado: (2021)

Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018)

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Cutaneous Adverse Reactions of Amiodarone
por: Jaworski, Krzysztof, et al.
Publicado: (2014)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines
por: Bellinato, Francesco, et al.
Publicado: (2021)

Competition for clinical cases in Alzheimer’s disease (CCCAD) – Janssen-Cilag
Publicado: (2008)

Safeguarding against use of contaminated COVID-19 Vaccine Janssen
Publicado: (2021)

L’EMA recommande le vaccin monodose de Janssen
por: Dalmat, Yann-Mickael
Publicado: (2021)

English-only labels for Janssen's COVID-19 vaccine in Canada
Publicado: (2021)

FDA limits authorised use of Janssen COVID-19 vaccine
Publicado: (2022)

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
por: Orime, Mari
Publicado: (2017)

Recent Advances in Severe Cutaneous Adverse Drug Reaction
por: Das, Sudip, et al.
Publicado: (2018)

Ad26.COV2.S COVID-19 vaccine: TTS a rare, but serious adverse event
Publicado: (2022)

Brain venography performance following the pause of Ad.26.COV2.S COVID-19 vaccine administration
por: Long, Clayton V., et al.
Publicado: (2021)

Persistent drop in confidence following US recommended pause of Ad26.COV2.S vaccine administration
por: Rader, Benjamin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l6rhvvrp37kmudvnktmf3dr12i